100/100 (Very Low)

OpenClaw： benign
VirusTotal： benign
StaticScan： clean

OpenClaw： benign

The skill's code, instructions, and requirements are coherent with an antibody-humanization tool and do not request unrelated credentials or network access, but provenance is limited so review before ...

[内容已截断]

VirusTotal： benign VT 报告

静态扫描： clean

No suspicious patterns detected.

README 未提供

{
    "latestVersion": {
        "_creationTime": 1773801914109,
        "_id": "k978hqqrc9tqgk5rsagjdcvjxx835g53",
        "changelog": "antibody-humanizer v0.1.0\n\n- Initial release with core antibody humanization functionalities.\n- Supports CDR identification using Kabat, Chothia, and IMGT schemes.\n- Matches murine antibody frameworks to optimal human germline templates.\n- Predicts essential back-mutations for antigen binding retention.\n- Provides multi-factor humanization scoring and immunogenicity assessment.\n- Enables batch processing of multiple antibody candidates.",
        "changelogSource": "auto",
        "createdAt": 1773801914109,
        "version": "0.1.0"
    },
    "owner": {
        "_creationTime": 0,
        "_id": "publishers:missing",
        "displayName": "AIpoch",
        "handle": "aipoch-ai",
        "image": "https:\/\/avatars.githubusercontent.com\/u\/258999481?v=4",
        "kind": "user",
        "linkedUserId": "kn76fcc8jhxekae91m2ekbrsgn821avs"
    },
    "ownerHandle": "aipoch-ai",
    "skill": {
        "_creationTime": 1773801914109,
        "_id": "kd7e9s4vdefk7gwanp1z353tsd834mjr",
        "badges": [],
        "createdAt": 1773801914109,
        "displayName": "Antibody Humanizer",
        "latestVersionId": "k978hqqrc9tqgk5rsagjdcvjxx835g53",
        "ownerUserId": "kn76fcc8jhxekae91m2ekbrsgn821avs",
        "slug": "antibody-humanizer",
        "stats": {
            "comments": 0,
            "downloads": 48,
            "installsAllTime": 0,
            "installsCurrent": 0,
            "stars": 0,
            "versions": 1
        },
        "summary": "Humanize murine antibody sequences using CDR grafting and framework optimization to reduce immunogenicity while preserving antigen binding. Predicts optimal...",
        "tags": {
            "latest": "k978hqqrc9tqgk5rsagjdcvjxx835g53"
        },
        "updatedAt": 1773802009284
    }
}